MENUNews Archive
Date: 09/21/2017
1:15 - 2:45pm
Dawn Owen, U-M Radiation Oncology: Utility of 4DMRI for Liver Radiation Planning [e-poster]
Abstract #165
Location: 5B
Date: 09/08/2017
As cancer grows, it evolves. Individual cells become more aggressive, break away to flow through the body and spread to distant areas. What if there were a way to find those early aggressors? How are they different from the rest of the cells? And more importantly: Is there a way to stop them before they spread?
Date: 09/02/2017
Author: Rosemary Clandos Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer Ans
Date: 09/01/2017
Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown. This information could be used to determine which patients are most likely to benefit from additional therapies to head off the spread of the cancer to other areas of the body.
Date: 08/28/2017
Individual acupressure points linked to specific centers in the brain can offer targeted relief for breast cancer patients with persistent fatigue, according to a new neuroimaging study.
Date: 08/25/2017
Reuters reports on a study published in European Urology that shows that black men in America with medium- and high-risk prostate tumors are less likely to get aggressive treatment than white men are.
Date: 08/25/2017
An experimental drug combined with the traditional chemotherapy drug cisplatin, when used in mice, destroyed a rare form of salivary gland tumor and prevented a recurrence within 300 days, a University of Michigan study found.
Date: 08/08/2017
Ranked No. 1 in Michigan and No. 12 in the country, The University of Michigan Rogel Cancer Center was recognized as among the best in the nation by U.S. News & World Report for 2017-2018.
Date: 08/02/2017
A new study shows just how complex metastatic cancer is and offers some clues to attacking it. The study represents one of the largest and most comprehensive efforts to examine the genetic and molecular landscape of advanced cancer.
Date: 07/21/2017
Michigan Medicine experts discuss whether active surveillance could reduce overtreatment for some thyroid, prostate and breast cancers